Danilo Toshio Kanno
Universidade São Francisco
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Danilo Toshio Kanno.
Cancer Biomarkers | 2011
Natalia Peres Martinez; Danilo Toshio Kanno; José Aires Pereira; Izilda Aparecida Cardinalli; Denise Gonçalves Priolli
AIM To investigate the relationship between beta-catenin and E-cadherin tissue quantitative expression (content) in tumors and clinical prognostic factors in patients with left colon cancer. MATERIAL AND METHODS Twenty nine patients with colon adenocarcinoma located distal to the splenic flexure were studied. Diagnosis and histological variables related to adenocarcinoma prognosis were evaluated using hematoxylin-eosin. Beta-catenin and E-cadherin were analysed by immunohistochemistry with specific anti-beta-catenin and anti-E-cadherin monoclonal antibodies. Tissue quantitative expression (content) was determined by computer assisted image analysis method. Results were analysed with statistical tests, adopting a significance level of 5%. RESULTS There are correlations between beta-catenin and TNM stage (p< 0.01). There are progressively greater amounts of beta-catenin in patients with deeper invasion of the tumor in colon layers (p=0.03), progressive lymph node involvement (p=0.05), as well as in patients with distant metastasis (p=0.04). Worse histological grades are related to lower expression of E-cadherin in tumor tissue (p=0.01). CONCLUSIONS E-cadherin can be used as an indicator of tumor differentiation degree, whereas beta-catenin can be used as a predictor of invasion depth and spread of distal colorectal cancer.
Acta Cirurgica Brasileira | 2017
Carlos Augusto Real Martinez; Caled Jaoudat Kadri; Danilo Toshio Kanno; Antonio José Tibúrcio Alves Junior; Cláudio Saddy Rodrigues Coy; José Aires Pereira
Purpose: To evaluate the inflammatory intensity and measure the tissue content of the proteins claudin-3 and occludin in the colonic mucosa without fecal stream submit to intervention with curcumin. Methods: Thirty-six rats were submitted to a proximal colostomy and a distal mucous fistula and divided into two groups according to sacrifice to be performed two or four weeks. Each group was divided into three subgroups according daily application of enemas containing saline, curcumin at 50 mg/kg/day or 200 mg/kg/day. Colitis was diagnosed by histological analysis. Claudin-3 and occludin were determined by immunohistochemistry. The tissue content of claudin-3 and occludin were quantified by computer-assisted image analysis. Mann-Whitney, Student t and ANOVA tests were used to analyze the results establishing the level of significance of 5% for both (p<0.05). Results: Curcumin at both concentrations reduces the inflammation and preserves the tissue content of the proteins claudin-3 and occludin, which was related to the concentration used and to the time of the intervention. Conclusion: The application of enemas with curcumin reduces inflammation and preserves the tissue content of the proteins claudin-3 and occludin in the colonic mucosa devoid from the fecal stream.
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) | 2017
Enzo Fabrício Ribeiro Nascimento; Marcelo Lima Ribeiro; Daniéla Oliveira Magro; Juliana Barboza de Carvalho; Danilo Toshio Kanno; Carlos Augusto Real Martinez; Cláudio Saddy Rodrigues Coy
ABSTRACT Background: MTUYH and OGG1 genes have importance in the base excision repair systems of oxidized DNA bases. Modification of the tissue expression of these genes is related to the increased risk of developing colorectal cancer. Aim: To evaluate the tissue expression of MUTYH and OGG1 comparing normal and neoplastic tissues of patients with sporadic colorectal cancer and to correlate it with clinical and histopathological variables. Method: MUTYH and OGG1 tissue expression was quantified by RT-PCR in patients with colorectal cancer and the values were compared in normal and neoplastic tissues. MUTYH and OGG1 expression was measured and normalized to the constitutive 18S gene. The level of expression of both genes was correlated with the variables: age, gender, tumor location, size of the tumor, histological type, degree of cell differentiation, invasion depth in the intestinal wall, angiolymphatic infiltration, lymph node involvement and TNM staging. Results: Was found downregulation of both genes in neoplastic when compared to normal tissue. There was downregulation of the MUTYH in larger tumors and in patients with angiolymphatic invasion. Tumors with more advanced TNM stages (III and IV) presented downregulation of both genes when compared to those with earlier stages (I and II). Conclusion: The MUTYH and OGG1 genes present downregulation in the more advanced stages of colorectal cancer.
Journal of Coloproctology | 2018
Bruna Zini de Paula Freitas; Enzo Fabrício do Nascimento; Ronaldo Nonose; Danilo Toshio Kanno; Roberta Lais dos Santos Mendonça; Carlos Augusto Real Martinez; Daniel de Castilho
Introdução: Os tumores estromais gastrointestinais (GIST) representam menos de 1% de todas as neoplasias malignas porém são as neoplasias mesenquimais mais comuns do trato gastrointestinal. Surgem da parede do trato gastrointestinal, provavelmente das células intersticiais de Cajal, que regular a motilidade do trato, e o marcador histoquímico mais importante é a proteína cKIT CD117, expresso em 95% dos casos. Mais raramente, neoplasias de características semelhantes podem originar-se fora do TGI, o qual denominamos de tumor estromal extragastrointestinal (EGIST), sendo o retroperitônio o local mais incomum de aparecimento. Caso: Paciente masculino, 73 anos, admitido em hospital terciário de Salvador (BA) com sangramento retal intermitente há 4 meses, de piora progressiva, associado a retenção urinária há 2 meses. Realizou colonoscopia evidenciando abaulamento importante junto à linha pectínea, de aspecto extra colônico. Submetido à Ressonância Magnética de Pelve evidenciando volumosa formação pré sacral de contornos bem definidos, hiperintensa em T2 e com numerosas áreas de degeneração hemorrágicas internas em íntimo contato e indissociável com parede posterior do reto (volume de 921 cm3); Fígado com 4 lesões focais de realce em meio ao contraste. Ao exame físico observava-se abaulamento com compressão extrínseca de lúmen de canal anal há 2 cm de borda anal. Submetido a amputação abdominoperineal de reto, em maio/2017, com resultado anátomopatológico de Neoplasia Fusocelular e estudo Imunohistoquímico conclusivo de GIST de alto grau histológico (pT4N0) com positividade para os anticorpos monoclonais desmin, CD34, cKIT CD117 e Smooth muscle actin. Encontra-se em tratamento quimioterápico com Mesilato de Imatinibe (Gleevec). Discussão: EGISTs são um grupo de tumores com histologia e imunoquimica idênticas aos GISTs. Entretanto a patogênese, incidência, fatores clínicos associados e prognóstico dos EGISTs não foram completamente elucidados. Localização, tamanho, celularidade, atividade mitótica e necrose são os preditores mais precisos de um desfecho desfavorável desses tumores. Eles crescem silenciosamente sendo descobertos causando sintomas de compressão. Conclusão: Relatamos aqui um caso de EGIST primário de retroperitônio tratado cirurgicamente. Trata-se de um caso singular onde a revisão da literatura demonstra que a correta relação clinicoradiológica é importante no diagnóstico diferencial para GIST e seu posterior tratamento imunossupressor/quimioterápico.
International Journal of Surgery Case Reports | 2018
Denise Graffitti D’Avila; Danilo Toshio Kanno; Daniel de Castilho da Silva; Vitor Rafael Pastro; Paula Cristina Stefen Novelli; Bruna Zini de Paula Freitasa; Carlos Augusto Real Martineza
Highlights • Proliferating trichilemmal cyst is a rare benign neoplasms from the hair follicles.• There are no reports of proliferating trichilemmal cyst in the perianal region.• The treatment for trichilemmal cyst is surgical excision with normal tissue margins.• The differential diagnosis of trichilemmal cyst include squamous cell carcinoma.
BMC Cancer | 2018
Jéssica Silva dos Santos; Gabriel Alves Bonafé; José Aires Pereira; Danilo Toshio Kanno; Carlos Augusto Real Martinez; Manoela Marques Ortega
BackgroundPerianal Paget’s disease (PPD) is a rare intraepithelial adenocarcinoma of the anal margin. Primary PPD likely represents intra-epithelial neoplasm from an apocrine source, whereas secondary disease may represent “pagetoid” spread from an anorectal malignancy.Case presentationHistologic CDX-2 and CK20 are hallmark markers for colorectal-derived Paget’s cells. Interestingly, our primary PPD patient presented both positive and no internal malignancy was identified. In addition, a negative CK7 marker was observed in our case in contrast with previously reported. Surgical excision is the standard treatment; however, previous studies have demonstrated good response with Imiquimod 5% cream in patients with vulval extramammary Paget disease (EMPD). The efficiency of Imiquimod treatment for PPD has not been well described. Our PPD patient was successfully treated using Imiquimod 5% cream.ConclusionsThis study describes a primary cutaneous PPD patient CDX-2+/CK20+/CK7- without invasion of the dermis and no associated colorectal carcinoma effectively treated using topical Imiquimod therapy, suggesting that Imiquimod might potentially be considered as a first-line treatment for PPD.
Journal of Coloproctology | 2017
Denise Graffitti D’Avila; Adrieli Heloisa Campardo Pansani; Vitor Rafael Pastro; Paula Cristina Stefen Novelli; Bruna Zini de Paula Freitas; Danilo Toshio Kanno; Carlos Augusto Real Martinez
A. total de exames FOBT efetuados: 5.732. B. total de FOBT positivos: 289 (5,04%) (b/a) = 289/5.732. C. total de positivos para câncer nas colonoscopias feitas:15 (0,26%) (c/a) = 15/5.732. D. colonoscopias feitas em FOBT + : 185. Doenças benignas ou exame normal: 68 (36,75%) (68/185); adenomas (baixo grau ou serrilhado): 101 (64,66%) (101/185); câncer: 15 (8,1%) (15/185). Câncer intramucoso ou adenomas de alto grau de atipia: oito (tratados por via endoscópica). Câncer invasivo: sete (tratamento cirúrgico:1 e ESD:1). Pacientes FOBT + que aguardam colonoscopia: 59; recusaram colonoscopia: 45.
Journal of Coloproctology | 2015
Carlos Augusto Real Martinez; Murilo Rocha Rodrigues; Daniela Tiemi Sato; Camila Morais Gonçalves da Silva; Danilo Toshio Kanno; Roberta Lais dos Santos Mendonça; José Aires Pereira
Journal of Gastrointestinal Cancer | 2016
José Ricardo Scalise; Regina Caeli Guerra Poças; Thamy Pelatieri Caneloi; Camila Oliveira Lopes; Danilo Toshio Kanno; Mayara Gonçalves Marques; Júlio Cesar Martins Valdivia; Felipe Rodrigues Máximo; José Aires Pereira; Marcelo Lima Ribeiro; Denise Gonçalves Priolli
Journal of Coloproctology | 2018
Bruna Zini de Paula Freitas; José Aires Pereira; Danilo Toshio Kanno; Paula Cristina Steffen Novelli; Fábio Guilherme Campos; Carlos Augusto Real Martinez